ghpvs | 20763
Polycythaemia vera (PV) sequential testing
Keywords:
JAK2 Mutation
JAK2 Mutation Exon 12
JAK2 p.V617F
Myeloproliferation
Myleoproliferative Neoplasm
PV
Polycythaemia Vera
Status
Material |
|
||
---|---|---|---|
Hint |
JAK2 p.V617F Mutation > JAK2 Mutation Exon 12. There is a possibility of excess information occurring with this analysis. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG (Federal Law on Genetic Testing in Humans) provides for the patient to be informed accordingly (see www.viollier.ch/en/SGMG_consent). |
||
Min. volume | 4 mL | ||
Stability |
Stability
1 day / 18-25°C; 4 days / 2-8°C
|
||
Duration | 5 days | ||
Frequency | 2 x per week | ||
Method | Next Generation Sequencing |
Price/Rate
Price |
Price
CHF 941.20
|
---|---|
Rate |
Rate
941.20 TP
|
Single Analysis
JAK2 Exon 12 Mutations | jak2e | Blood EDTA |
---|---|---|
JAK2 p.V617F Mutation course (quantitative) | jak2q | Blood EDTA |